| Dec'19 | Dec'18 | Dec'17 | Dec'16 | Dec'15 | Dec'14 | Dec'13 | Dec'12 | Dec'11 | Dec'10 | Dec'09 |
|---|---|---|---|---|---|---|---|---|---|---|
Operating activities | ||||||||||
Net loss | ||||||||||
-4,627 | 736 | -35,730 | 14,302 | 21,640 | 2,475 | 264 | -4,924 | -3,342 | -6,214 | 608 |
Adjustments to reconcile net income to net cash provided by operating activities: | ||||||||||
Depreciation | ||||||||||
6,281 | 7,331 | 7,903 | 7,576 | 1,935 | 1,579 | 1,682 | 1,898 | 2,765 | 3,815 | 4,588 |
Amortization of intangible assets | ||||||||||
1,794 | 1,390 | 3,161 | - | - | - | - | - | - | - | - |
Amortization of intangible assets | ||||||||||
- | - | - | 2,313 | 506 | 356 | 231 | 233 | 331 | 435 | 590 |
Provision for bad debt | ||||||||||
129 | 53 | 174 | 542 | 266 | 311 | -150 | -30 | 237 | 832 | 58 |
Stock-based compensation | ||||||||||
540 | 634 | 852 | 1,024 | 616 | 326 | 340 | 630 | 800 | 891 | 606 |
Amortization of loan fees | ||||||||||
-185 | -43 | -177 | -368 | 0 | 0 | - | - | - | - | - |
Debt issuance costs written-off | ||||||||||
-151 | -43 | -709 | 0 | 0 | - | - | - | - | - | - |
Loss on write-off of financing costs | ||||||||||
273 | 0 | - | - | - | - | - | - | - | - | - |
Gain on disposal of discontinued operations | ||||||||||
350 | 6,161 | - | - | - | - | - | - | - | - | - |
Goodwill impairment | ||||||||||
- | - | - | 338 | 0 | 0 | - | - | - | - | - |
Gain on sale of Telerhythmics | ||||||||||
0 | 19 | - | - | - | - | - | - | - | - | - |
Restructuring loss | ||||||||||
- | - | - | - | - | - | - | - | - | 355 | 319 |
Loss (gain) on sale of assets | ||||||||||
136 | 46 | 66 | 83 | -67 | 77 | 1,621 | 104 | 103 | -154 | 26 |
Unrealized (gain) loss on equity securities | ||||||||||
62 | -62 | -311 | - | - | - | - | - | - | - | - |
Goodwill impairment | ||||||||||
0 | 476 | 2,746 | - | - | - | - | - | - | - | - |
Goodwill tax adjustment | ||||||||||
-265 | 0 | - | - | - | - | - | - | - | - | - |
Impairment of investment | ||||||||||
- | - | - | 413 | 233 | - | - | - | - | - | - |
Amortization of premium on investments | ||||||||||
- | - | - | -30 | -115 | -198 | -192 | -140 | -286 | -285 | -454 |
Deferred income taxes | ||||||||||
98 | 133 | -27,530 | 12,479 | 18,599 | -21 | 0 | - | - | - | - |
Other, net | ||||||||||
- | - | 160 | 0 | 0 | - | - | - | - | - | - |
Changes in operating assets and liabilities: | ||||||||||
Accounts receivable | ||||||||||
3,325 | -3,026 | 1,567 | 1,144 | 1,246 | 614 | -1,049 | -21 | -970 | 806 | -1,713 |
Inventories | ||||||||||
30 | 12 | -409 | 1,349 | 811 | -300 | -1,136 | -1,057 | 1,046 | -1,280 | 1,565 |
Other assets | ||||||||||
317 | -686 | 14 | -1,384 | -197 | 302 | 90 | -127 | -6 | -196 | -809 |
Accounts payable | ||||||||||
-463 | 25 | -1,244 | 439 | -203 | 776 | -935 | 216 | -364 | 74 | -400 |
Accrued compensation | ||||||||||
211 | -1,645 | 1,545 | -1,100 | -889 | -380 | 1,108 | 73 | 691 | -912 | -1,295 |
Deferred revenue | ||||||||||
155 | -749 | 6 | - | - | - | - | - | - | - | - |
Deferred revenue | ||||||||||
- | - | - | -347 | 29 | 13 | -218 | -250 | -280 | -215 | -129 |
Operating lease liabilities | ||||||||||
-37 | 0 | - | - | - | - | - | - | - | - | - |
Other liabilities | ||||||||||
391 | -676 | -673 | -1,393 | -380 | -469 | -787 | -119 | 208 | 59 | -1,524 |
Restricted cash | ||||||||||
- | - | - | 0 | -244 | 233 | 0 | 50 | 194 | 0 | 0 |
Net cash provided by (used in) operating activities | ||||||||||
400 | 5,064 | 6,069 | 10,834 | 3,720 | 4,280 | 2,201 | -1,082 | 965 | 229 | 4,806 |
Investing activities | ||||||||||
Purchases of property and equipment | ||||||||||
1,512 | 2,163 | 2,531 | 6,185 | 1,424 | 1,258 | 726 | 936 | 709 | 1,437 | 1,014 |
Proceeds from sale of discontinued operations | ||||||||||
0 | 6,844 | - | - | - | - | - | - | - | - | - |
Proceeds from sale of property and equipment | ||||||||||
1,734 | 2,095 | 167 | 266 | 18 | 103 | 1,697 | 118 | 165 | 55 | 1,024 |
Purchase of real estate from related and third parties | ||||||||||
5,180 | 0 | - | - | - | - | - | - | - | - | - |
Purchases of securities available-for-sale | ||||||||||
- | - | - | 0 | 0 | 2,617 | 4,679 | 4,887 | 13,086 | 5,477 | 20,360 |
Proceeds from sales of equity securities | ||||||||||
- | - | 917 | 2,290 | 4,602 | 2,140 | 4,474 | 3,465 | 16,145 | 13,569 | 16,586 |
Sale (purchases) of equity securities | ||||||||||
140 | - | - | - | - | - | - | - | - | - | - |
Sale (purchases) of equity securities | ||||||||||
- | 13 | 18 | 0 | 1,000 | 0 | 0 | - | - | - | - |
Payments to acquire interest in joint ventures | ||||||||||
1,000 | 0 | - | - | - | - | - | - | - | - | - |
Payments to acquire interest in joint ventures | ||||||||||
- | - | - | 25,482 | -3 | 3,447 | 0 | 475 | 0 | 0 | - |
Net cash used in investing activities | ||||||||||
-5,818 | 8,685 | -1,465 | -29,111 | 2,199 | -5,079 | 766 | -2,715 | 2,515 | 6,710 | -3,764 |
Financing activities | ||||||||||
Proceeds from borrowings | ||||||||||
98,541 | 33,347 | 37,569 | 37,007 | 0 | 0 | - | - | - | - | - |
Repayment of debt | ||||||||||
91,203 | 43,347 | 40,032 | 24,794 | 0 | 131 | 0 | 0 | - | - | - |
Issuances of preferred stock | ||||||||||
3,000 | 0 | - | - | - | - | - | - | - | - | - |
Change in restricted cash | ||||||||||
- | - | - | -3,143 | 0 | 0 | - | - | - | - | - |
Loan issuance costs | ||||||||||
662 | -24 | 271 | 504 | 300 | 0 | 0 | - | - | - | - |
Dividends paid | ||||||||||
0 | 3,321 | 4,195 | 3,913 | 3,833 | 3,713 | 925 | 0 | 0 | - | - |
Issuances of common stock | ||||||||||
0 | 26 | 5 | 822 | 624 | 188 | 919 | 300 | 119 | 44 | 36 |
Repayment of Gerber acquisition loan | ||||||||||
3,000 | 0 | - | - | - | - | - | - | - | - | - |
Fees payable on issuance of preferred stock | ||||||||||
150 | 0 | - | - | - | - | - | - | - | - | - |
Deferred financing costs | ||||||||||
27 | 0 | - | - | - | - | - | - | - | - | - |
Taxes paid related to net share settlement of equity awards | ||||||||||
24 | 74 | 195 | 97 | 0 | 0 | 3,642 | 1,028 | 19 | 48 | 991 |
Cash paid for contingent consideration for acquisitions | ||||||||||
- | - | 27 | 27 | 0 | 0 | - | - | - | - | - |
Repayment of obligations under finance leases | ||||||||||
863 | 811 | 917 | 739 | 593 | 238 | 89 | 0 | 0 | 36 | 52 |
Net cash (used in) provided by financing activities | ||||||||||
5,666 | -14,156 | -8,063 | 4,612 | -4,102 | -3,894 | -3,737 | -728 | 100 | -40 | -1,007 |
Net decrease in cash, cash equivalents, and restricted cash | ||||||||||
- | - | -3,459 | -13,665 | 1,817 | -4,693 | -770 | -4,525 | 3,580 | 6,899 | 35 |
Net decrease in cash, cash equivalents, and restricted cash | ||||||||||
248 | -407 | - | - | - | - | - | - | - | - | - |
Supplemental Information | ||||||||||
Cash paid during the period for interest | ||||||||||
1,083 | 702 | 856 | - | - | - | - | - | - | - | - |
Cash paid during the period for interest | ||||||||||
- | - | - | 936 | 0 | 0 | - | - | - | - | 9 |
Cash paid during the period for income taxes | ||||||||||
102 | 52 | 127 | 286 | 62 | 99 | - | - | - | - | - |
Assets acquired by entering into capital lease | ||||||||||
- | - | 2,422 | 329 | 1,393 | 521 | 490 | 83 | - | - | - |
Other than Temporary Impairment Losses, Investments, Portion Recognized in Earnings, Net | ||||||||||
- | - | - | - | - | 0 | - | - | - | - | - |
Leasehold improvements paid for by lessor | ||||||||||
- | - | - | - | - | 212 | 0 | 0 | - | - | - |
Issuances of common stock for acquisitions | ||||||||||
- | - | - | 0 | 2,684 | 0 | 0 | - | - | - | - |
Purchase of assets under capital leases | ||||||||||
- | - | - | - | - | - | - | - | - | - | 113 |
Medical Device Sales And Service Post-Warranty Service Business | ||||||||||
Gain on disposal of discontinued operations | ||||||||||
- | - | 0 | - | - | - | - | - | - | - | - |
Proceeds from sale of discontinued operations | ||||||||||
- | - | 0 | - | - | - | - | - | - | - | - |
Telerhythmics | ||||||||||
Gain on disposal of discontinued operations | ||||||||||
- | - | 0 | - | - | - | - | - | - | - | - |
Goodwill impairment | ||||||||||
- | - | 166 | - | - | - | - | - | - | - | - |
Proceeds from sale of discontinued operations | ||||||||||
0 | 1,922 | 0 | - | - | - | - | - | - | - | - |